Whole-body scanning PCR; a highly sensitive method to study the biodistribution of mRNAs, noncoding RNAs and therapeutic oligonucleotides.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3753639)

Published in Nucleic Acids Res on June 13, 2013

Authors

Julien A Boos1, David W Kirk, Mari-Luz Piccolotto, Werner Zuercher, Sandro Gfeller, Philippe Neuner, Andre Dattler, William L Wishart, Fabian Von Arx, Michael Beverly, Jesper Christensen, Karine Litherland, Esther van de Kerkhof, Pieter J Swart, Thomas Faller, Armin Beyerbach, David Morrissey, Juerg Hunziker, Iwan Beuvink

Author Affiliations

1: Novartis Institutes for Biomedical Research (NIBR), Novartis Pharma AG, Basel, Basel-Stadt CH-4056, Switzerland and NIBR, Novartis Pharma AG, Cambridge, Massachusetts, MA 02139, USA.

Articles citing this

Quantitative PCR analysis of DNA aptamer pharmacokinetics in mice. Nucleic Acid Ther (2014) 0.75

Articles cited by this

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19

Identification of tissue-specific microRNAs from mouse. Curr Biol (2002) 34.55

A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03

Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res (2005) 29.17

Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol (2004) 15.15

The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc (2006) 5.41

Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. RNA (2005) 5.20

In vivo imaging of siRNA delivery and silencing in tumors. Nat Med (2007) 4.94

Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem (1991) 4.34

Synthetic genetic polymers capable of heredity and evolution. Science (2012) 3.59

Genomic DNA standards for gene expression profiling in Mycobacterium tuberculosis. Nucleic Acids Res (2002) 2.94

A transgenic mouse for in vivo detection of endogenous labeled mRNA. Nat Methods (2011) 2.27

Myelin basic protein: a multifunctional protein. Cell Mol Life Sci (2006) 2.23

Chemical modification of siRNAs for in vivo use. Oligonucleotides (2008) 2.03

Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats. J Pharmacol Exp Ther (2001) 1.73

Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther (2011) 1.36

Detecting RNA and DNA with templated chemical reactions. Chem Rev (2006) 1.31

Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci (2011) 1.24

"Per cell" normalization method for mRNA measurement by quantitative PCR and microarrays. BMC Genomics (2006) 1.18

Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acids Res (2000) 1.16

Examination of real-time polymerase chain reaction methods for the detection and quantification of modified siRNA. Anal Biochem (2008) 1.05

Stem-loop RT-PCR quantification of siRNAs in vitro and in vivo. Oligonucleotides (2009) 1.05

Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis. Expert Opin Drug Deliv (2011) 1.01

Recent advances of siRNA delivery by nanoparticles. Expert Opin Drug Deliv (2011) 0.96

Liver-specific and proliferation-induced deoxyribonuclease I hypersensitive sites in the mouse insulin-like growth factor binding protein-1 gene. Hepatology (1999) 0.95

Ultrasensitive detection of protein using an aptamer-based exonuclease protection assay. Anal Chem (2004) 0.95

Anti-primer quenching-based real-time PCR for simplex or multiplex DNA quantification and single-nucleotide polymorphism genotyping. Nat Protoc (2007) 0.93

Ultrasensitive detection of proteins by amplification of affinity aptamers. Angew Chem Int Ed Engl (2006) 0.89

In vivo imaging with oligonucleotides for diagnosis and drug development. Gut (2003) 0.86

Slow non-specific accumulation of 2'-deoxy and 2'-O-methyl oligonucleotide probes at mitochondria in live cells. Nucleic Acids Res (2010) 0.84

Amplified microRNA detection by templated chemistry. Nucleic Acids Res (2012) 0.83

Quantitative whole-body autoradiography. Regul Toxicol Pharmacol (2000) 0.81

A chemical 5'-phosphorylation of oligodeoxyribonucleotides. DNA (1986) 0.80

Aptamer-Based Sensitive Detection of Target Molecules via RT-PCR Signal Amplification. Bioconjug Chem (2010) 0.78

Aptamer-based regionally protected PCR for protein detection. Clin Chem (2009) 0.77

Articles by these authors

UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature (2007) 8.32

TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature (2011) 8.31

Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev (2008) 5.25

The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature (2006) 4.74

Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J Exp Med (2004) 3.63

Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2. Genes Dev (2008) 3.10

The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev (2009) 3.04

A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation. Mol Cell (2010) 2.77

Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells. Cancer Res (2004) 2.64

The emerging functions of histone demethylases. Curr Opin Genet Dev (2008) 2.47

DNA methylation: TET proteins-guardians of CpG islands? EMBO Rep (2011) 2.23

Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol Cell (2013) 1.78

ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Cancer Res (2009) 1.60

Improved luciferase tagging system for Listeria monocytogenes allows real-time monitoring in vivo and in vitro. Appl Environ Microbiol (2007) 1.54

Human XPA and RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions. Proc Natl Acad Sci U S A (2002) 1.49

Tet2 facilitates the derepression of myeloid target genes during CEBPα-induced transdifferentiation of pre-B cells. Mol Cell (2012) 1.43

Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica (2013) 1.40

The histone demethylase PHF8 governs retinoic acid response in acute promyelocytic leukemia. Cancer Cell (2013) 1.38

Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. J Neurochem (2007) 1.30

Human XPC-hHR23B interacts with XPA-RPA in the recognition of triplex-directed psoralen DNA interstrand crosslinks. Nucleic Acids Res (2005) 1.27

Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19. J Med Virol (2002) 1.18

Discovery of alpha,gamma-diketo acids as potent selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase. J Med Chem (2004) 1.16

PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation. Genome Biol (2013) 1.13

Designing threshold networks with given structural and dynamical properties. Phys Rev E Stat Nonlin Soft Matter Phys (2006) 1.12

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors. Mol Ther (2010) 1.11

The demethylase JMJD2C localizes to H3K4me3-positive transcription start sites and is dispensable for embryonic development. Mol Cell Biol (2014) 1.07

Pharmacokinetics, distribution, metabolism, and excretion of deferasirox and its iron complex in rats. Drug Metab Dispos (2008) 1.06

Examination of real-time polymerase chain reaction methods for the detection and quantification of modified siRNA. Anal Biochem (2008) 1.05

ERBB4/HER4 potentiates STAT5A transcriptional activity by regulating novel STAT5A serine phosphorylation events. J Biol Chem (2005) 1.04

A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy. Hum Gene Ther (2010) 1.03

Interplay between human high mobility group protein 1 and replication protein A on psoralen-cross-linked DNA. Biochemistry (2005) 1.03

Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitors. J Med Chem (2007) 0.98

Essential functions of p21-activated kinase 1 in morphogenesis and differentiation of mammary glands. J Cell Biol (2003) 0.97

Independent combinatorial effect of antisense oligonucleotides and RNAi-mediated specific inhibition of the recombinant rat P2X3 receptor. Nucleic Acids Res (2003) 0.97

Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV. J Biol Chem (2004) 0.93

Pharmacokinetics and safety of solifenacin succinate in healthy young men. J Clin Pharmacol (2004) 0.92

Sonoporation mediated immunogene therapy of solid tumors. Ultrasound Med Biol (2010) 0.90

Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV. Biochem J (2006) 0.90

Assessing the impacts of long-range sulfur and nitrogen deposition on arctic and sub-arctic ecosystems. Ambio (2010) 0.89

Biodistribution and metabolism studies of lipid nanoparticle-formulated internally [3H]-labeled siRNA in mice. Drug Metab Dispos (2014) 0.87

Arctic atmospheric contaminants in NE Greenland: levels, variations, origins, transport, transformations and trends 1990-2001. Sci Total Environ (2004) 0.86

A simple, rapid and sensitive method for simultaneous determination of rivastigmine and its major metabolite NAP 226-90 in rat brain and plasma by reversed-phase liquid chromatography coupled to electrospray ionization mass spectrometry. Biomed Chromatogr (2004) 0.86

Differential screening of phage-ab libraries by oligonucleotide microarray technology. PLoS One (2008) 0.84

Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen. J Med Virol (2002) 0.83

Trimerization of apolipoprotein A-I retards plasma clearance and preserves antiatherosclerotic properties. J Cardiovasc Pharmacol (2008) 0.83

Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists: variations on the 1H-pyrimidin-2-one theme. Bioorg Med Chem Lett (2006) 0.82

Prediction of the pharmacokinetics of succinylated human serum albumin in man from in vivo disposition data in animals and in vitro liver slice incubations. Eur J Pharm Sci (2005) 0.82

A new technique for preparing precision-cut slices from small intestine and colon for drug biotransformation studies. J Pharmacol Toxicol Methods (2004) 0.81

Metabolite identification of small interfering RNA duplex by high-resolution accurate mass spectrometry. Rapid Commun Mass Spectrom (2008) 0.81

Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis. Drug Deliv (2002) 0.81

Metabolism studies of unformulated internally [3H]-labeled short interfering RNAs in mice. Drug Metab Dispos (2013) 0.81

Intercomparison study of atmospheric mercury models: 2. Modelling results vs. long-term observations and comparison of country deposition budgets. Sci Total Environ (2007) 0.80

TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells. Stem Cells (2014) 0.80

Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer. Exp Biol Med (Maywood) (2011) 0.79

Sequence confirmation of modified oligonucleotides using chemical degradation, electrospray ionization, time-of-flight, and tandem mass spectrometry. Anal Chem (2008) 0.78

A role for oligonucleotide-based RNA-knock down technologies in functional genomics. Nucleosides Nucleotides Nucleic Acids (2003) 0.77

Rational combinatorial chemistry-based selection, synthesis and evaluation of an affinity adsorbent for recombinant human clotting factor VII. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.77

Intercomparison study of atmospheric mercury models: 1. Comparison of models with short-term measurements. Sci Total Environ (2007) 0.76

Molecular dosimetry of N7-(2-hydroxypropyl)guanine in tissues of F344 rats after inhalation exposure to propylene oxide. Carcinogenesis (2003) 0.75

Feasibility of the hydrogen sulfide test for the assessment of drinking water quality in post-earthquake Haiti. Environ Monit Assess (2014) 0.75

Ethylene oxide in blood of ethylene-exposed B6C3F1 mice, Fischer 344 rats, and humans. Toxicol Sci (2013) 0.75

Hemoglobin and DNA adducts in rats exposed to 2-nitrotoluene. Carcinogenesis (2003) 0.75

The use of strong anion-exchange (SAX) magnetic particles for the extraction of therapeutic siRNA and their analysis by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom (2011) 0.75